An evaluation of the eCOVID19 Recommendation Map identified
diverging Clinical and Public Health guidance

J 2022

An evaluation of the eCOVID19 Recommendation Map identified diverging Clinical and Public Health guidance

NASIR, Z. H., D. MERTZ, R. NIEUWLAAT, N. SANTESSO, T. LOTFI et. al.

Basic information

Original name

An evaluation of the eCOVID19 Recommendation Map identified diverging Clinical and Public Health guidance

Authors

NASIR, Z. H., D. MERTZ, R. NIEUWLAAT, N. SANTESSO, T. LOTFI, A. MOTILALL, L. MOJA, L. MBUAGBAW, Miloslav KLUGAR (203 Czech Republic, belonging to the institution), A. F. TURGEON, J. L. MATHEW, C. CANELO-AYBAR, K. POTTIE, O. DEWIDAR, M. W. LANGENDAM, A. IORIO, G. E. VIST, J. J. MEERPOHL, S. FLOTTORP, T. KREDO, T. PIGGOTT, M. MATHEWS, A. QASEEM, D. K. CHU, P. TUGWELL, Jitka KLUGAROVÁ (203 Czech Republic, belonging to the institution), H. NELSON, H. HUSSEIN, J. SUVADA, I. NEUMANN and H. J. SCHÜNEMANN (guarantor)

Edition

Journal of Clinical Epidemiology, New York, Elsevier, 2022, 0895-4356

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30304 Public and environmental health

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

URL

Impact factor

Impact factor: 7.200

RIV identification code

RIV/00216224:14110/22:00125668

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.jclinepi.2022.03.008

UT WoS

000808123800005

Keywords in English

COVID-19; Divergence; Discordance; GRADE; Guidelines; Recommendations

Abstract

V originále

Objective To describe divergence between actionable statements issued by COVID-19 guideline developers catalogued on the “COVID-19 Recommendations and Gateway to Contextualization” platform. Study Design and Setting We defined divergence as at least two comparable actionable statements with different explicit judgements of strength, direction or subgroup consideration of the population or intervention. We applied content analysis to compare guideline development methods for a sample of diverging statements and to evaluate factors associated with divergence. Results Of the 138 guidelines evaluated, 85 (62%) contained at least one statement that diverged from another guideline. We identified 223 diverging statements in these 85 guidelines. We grouped statements into 66 clusters. Each cluster addressed the same population, intervention, and comparator group or just similar interventions. Clinical practice statements were more likely to diverge in explicit judgment of strength or direction compared to public health statements (Cramer’s V = 0.7, Fisher’s exact test; P <0.001). Statements were more likely to diverge in strength than direction. Date of publication, utilized evidence, interpretation of evidence, and contextualization considerations were associated with divergence. Conclusion More than half of the assessed guidelines issued at least one diverging statement. This study helps understanding the types of differences between guidelines issuing comparable statements and factors associated with their divergence.

Citovat

NASIR, Z. H., D. MERTZ, R. NIEUWLAAT, N. SANTESSO, T. LOTFI, A. MOTILALL, L. MOJA, L. MBUAGBAW, Miloslav KLUGAR, A. F. TURGEON, J. L. MATHEW, C. CANELO-AYBAR, K. POTTIE, O. DEWIDAR, M. W. LANGENDAM, A. IORIO, G. E. VIST, J. J. MEERPOHL, S. FLOTTORP, T. KREDO, T. PIGGOTT, M. MATHEWS, A. QASEEM, D. K. CHU, P. TUGWELL, Jitka KLUGAROVÁ, H. NELSON, H. HUSSEIN, J. SUVADA, I. NEUMANN and H. J. SCHÜNEMANN. An evaluation of the eCOVID19 Recommendation Map identified diverging Clinical and Public Health guidance. Journal of Clinical Epidemiology. New York: Elsevier, 2022, vol. 147, July 2022, p. 83-94. ISSN 0895-4356. Available from: https://dx.doi.org/10.1016/j.jclinepi.2022.03.008.

@article{1847084,
   author = {Nasir, Z. H. and Mertz, D. and Nieuwlaat, R. and Santesso, N. and Lotfi, T. and Motilall, A. and Moja, L. and Mbuagbaw, L. and Klugar, Miloslav and Turgeon, A. F. and Mathew, J. L. and CaneloandAybar, C. and Pottie, K. and Dewidar, O. and Langendam, M. W. and Iorio, A. and Vist, G. E. and Meerpohl, J. J. and Flottorp, S. and Kredo, T. and Piggott, T. and Mathews, M. and Qaseem, A. and Chu, D. K. and Tugwell, P. and Klugarová, Jitka and Nelson, H. and Hussein, H. and Suvada, J. and Neumann, I. and Schünemann, H. J.},
   article_location = {New York},
   article_number = {July 2022},
   doi = {http://dx.doi.org/10.1016/j.jclinepi.2022.03.008},
   keywords = {COVID-19; Divergence; Discordance; GRADE; Guidelines; Recommendations},
   language = {eng},
   issn = {0895-4356},
   journal = {Journal of Clinical Epidemiology},
   title = {An evaluation of the eCOVID19 Recommendation Map identified diverging Clinical and Public Health guidance},
   url = {https://www.sciencedirect.com/science/article/pii/S0895435622000695},
   volume = {147},
   year = {2022}
}

TY  - JOUR
ID  - 1847084
AU  - Nasir, Z. H. - Mertz, D. - Nieuwlaat, R. - Santesso, N. - Lotfi, T. - Motilall, A. - Moja, L. - Mbuagbaw, L. - Klugar, Miloslav - Turgeon, A. F. - Mathew, J. L. - Canelo-Aybar, C. - Pottie, K. - Dewidar, O. - Langendam, M. W. - Iorio, A. - Vist, G. E. - Meerpohl, J. J. - Flottorp, S. - Kredo, T. - Piggott, T. - Mathews, M. - Qaseem, A. - Chu, D. K. - Tugwell, P. - Klugarová, Jitka - Nelson, H. - Hussein, H. - Suvada, J. - Neumann, I. - Schünemann, H. J.
PY  - 2022
TI  - An evaluation of the eCOVID19 Recommendation Map identified diverging Clinical and Public Health guidance
JF  - Journal of Clinical Epidemiology
VL  - 147
IS  - July 2022
SP  - 83-94
EP  - 83-94
PB  - Elsevier
SN  - 08954356
KW  - COVID-19
KW  - Divergence
KW  - Discordance
KW  - GRADE
KW  - Guidelines
KW  - Recommendations
UR  - https://www.sciencedirect.com/science/article/pii/S0895435622000695
N2  - Objective To describe divergence between actionable statements issued by COVID-19 guideline developers catalogued on the “COVID-19 Recommendations and Gateway to Contextualization” platform. Study Design and Setting We defined divergence as at least two comparable actionable statements with different explicit judgements of strength, direction or subgroup consideration of the population or intervention. We applied content analysis to compare guideline development methods for a sample of diverging statements and to evaluate factors associated with divergence. Results Of the 138 guidelines evaluated, 85 (62%) contained at least one statement that diverged from another guideline. We identified 223 diverging statements in these 85 guidelines. We grouped statements into 66 clusters. Each cluster addressed the same population, intervention, and comparator group or just similar interventions. Clinical practice statements were more likely to diverge in explicit judgment of strength or direction compared to public health statements (Cramer’s V = 0.7, Fisher’s exact test; P <0.001). Statements were more likely to diverge in strength than direction. Date of publication, utilized evidence, interpretation of evidence, and contextualization considerations were associated with divergence. Conclusion More than half of the assessed guidelines issued at least one diverging statement. This study helps understanding the types of differences between guidelines issuing comparable statements and factors associated with their divergence.
ER  -

NASIR, Z. H., D. MERTZ, R. NIEUWLAAT, N. SANTESSO, T. LOTFI, A. MOTILALL, L. MOJA, L. MBUAGBAW, Miloslav KLUGAR, A. F. TURGEON, J. L. MATHEW, C. CANELO-AYBAR, K. POTTIE, O. DEWIDAR, M. W. LANGENDAM, A. IORIO, G. E. VIST, J. J. MEERPOHL, S. FLOTTORP, T. KREDO, T. PIGGOTT, M. MATHEWS, A. QASEEM, D. K. CHU, P. TUGWELL, Jitka KLUGAROVÁ, H. NELSON, H. HUSSEIN, J. SUVADA, I. NEUMANN and H. J. SCHÜNEMANN. An evaluation of the eCOVID19 Recommendation Map identified diverging Clinical and Public Health guidance. \textit{Journal of Clinical Epidemiology}. New York: Elsevier, 2022, vol.~147, July 2022, p.~83-94. ISSN~0895-4356. Available from: https://dx.doi.org/10.1016/j.jclinepi.2022.03.008.

Detailed Information on Publication Record